Danaparoid and gastrointestinal haemorrhage Patient Reports February 13, 2012

Danaparoid Side Effects Report #5063665-X
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on July 18, 2006. Male patient, 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, melaena, purulent discharge, respiratory disorder. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4968053-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, haemoglobin decreased. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #4977383-7
Danaparoid side effect was reported by a Physician from JAPAN on Apr 03, 2006. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, laboratory test abnormal. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5026915-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2006. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood urea increased, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemoglobin decreased. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.


Danaparoid Side Effects Report #5121582-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 21, 2006. Male patient, 87 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: catheter related complication, gastrointestinal haemorrhage, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with PROPOFOL, DOPAMINE, METHYLPREDNISOLONE SUCCINATE, ANTITHROMBIN III, DOUBUTAMINE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, MEROPENEM TRIHYDRATE, IMMUNE GLOBULIN INTRAVENOUS. Patient recovered.

Danaparoid Side Effects Report #5116964-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, postoperative infection. Danaparoid dosage: unknown. During the same period patient was treated with CILASTATIN W, IMMUNE GLOBULIN INTRAVENOUS, ANTITHROMBIN III, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, MICAFUNGIN, ULINASTATIN, HYDROCORTISONE PHOSPHATE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5020297-7
Danaparoid side effect was reported by a Consumer or non-health professional from ARMENIA on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, cerebral haemorrhage, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #5020449-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #4976157-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, condition aggravated, gastrointestinal haemorrhage, haemorrhagic diathesis, hyperkalaemia, jaundice , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, SULPERAZON, PREDNISOLONE ACETATE OPHTHALMIC, AZASETRON HYDROCHLORIDE, PIRARUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CARBENIN. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #5108484-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5110463-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5116971-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5033186-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dehydration, gastrointestinal haemorrhage, infection . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, SIVELESTAT, CIPROFLOXACIN HYDROCHLORIDE, PRIMAXIN, VANCOMYCIN. Patient died.

Danaparoid Side Effects Report #5035204-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 16, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, RAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN SODUIM, GABEXATE MESILATE, CARPERITIDE. Patient died.


Danaparoid Side Effects Report #4991406-0
Danaparoid side effect was reported by a Health Professional from AFGHANISTAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #4995842-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous, haemorrhagic diathesis, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5033187-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 13, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastrointestinal haemorrhage, haemorrhage subcutaneous, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #4873368-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2005. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood pressure decreased, gastrointestinal haemorrhage, haemoglobin decreased, haemoptysis. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIFAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE. Patient died.

Danaparoid Side Effects Report #4948454-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatine increased, blood potassium increased, blood pressure decreased, gastrointestinal haemorrhage, haemoglobin decreased, haemoptysis, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIPAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE. Patient died.


Danaparoid Side Effects Report #4990413-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood pressure decreased, gastrointestinal haemorrhage, haemoptysis, laboratory test abnormal, melaena. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIFAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE, DOPAMINE. Patient died.

Danaparoid Side Effects Report #5148279-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 17 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, condition aggravated, gastrointestinal haemorrhage, multi-organ failure. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, CEFPIROME SULPHATE, ANTITHROMBIN III, FAMOTIDINE, METHYLPREDNISOLONE SUCCINATE, ULINASTATIN, OMEPRAZOLE, GABEXATE MESILATE. Patient died.

Danaparoid Side Effects Report #5113492-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with CILASTATIN W, IMMUNE GLOBULIN INTRAVENOUS, ANTITHROMBIN III, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, MICAFUNGIN, ULINASTATIN, HYDROCORTISONE PHOSPHATE. Patient recovered.

Danaparoid Side Effects Report #4932635-1
Danaparoid side effect was reported by a Health Professional from FRANCE on Feb 21, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anti-platelet antibody positive, catheter site haemorrhage, gastrointestinal haemorrhage, haematoma, haemothorax, leukocytosis, multi-organ failure, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4939443-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematoma, haemothorax, leukocytosis, multi-organ failure, platelet count decreased, post procedural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.